These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


76 related items for PubMed ID: 15145622

  • 1. Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function.
    Vourc'h P, Andres C.
    Brain Res Brain Res Rev; 2004 May; 45(2):115-24. PubMed ID: 15145622
    [Abstract] [Full Text] [Related]

  • 2. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z.
    Nature; 2002 Jun 27; 417(6892):941-4. PubMed ID: 12068310
    [Abstract] [Full Text] [Related]

  • 3. Oligodendrocyte maturation is inhibited by bone morphogenetic protein.
    See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB.
    Mol Cell Neurosci; 2004 Aug 27; 26(4):481-92. PubMed ID: 15276151
    [Abstract] [Full Text] [Related]

  • 4. Temporospatial expression and cellular localization of oligodendrocyte myelin glycoprotein (OMgp) after traumatic spinal cord injury in adult rats.
    Dou F, Huang L, Yu P, Zhu H, Wang X, Zou J, Lu P, Xu XM.
    J Neurotrauma; 2009 Dec 27; 26(12):2299-311. PubMed ID: 19580419
    [Abstract] [Full Text] [Related]

  • 5. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
    Huang JY, Wang YX, Gu WL, Fu SL, Li Y, Huang LD, Zhao Z, Hang Q, Zhu HQ, Lu PH.
    Brain Res; 2012 Feb 09; 1437():1-15. PubMed ID: 22227458
    [Abstract] [Full Text] [Related]

  • 6. Oligodendrocyte differentiation and myelination defects in OMgp null mice.
    Lee X, Hu Y, Zhang Y, Yang Z, Shao Z, Qiu M, Pepinsky B, Miller RH, Mi S.
    Mol Cell Neurosci; 2011 Apr 09; 46(4):752-61. PubMed ID: 21352918
    [Abstract] [Full Text] [Related]

  • 7. LINGO-1 negatively regulates myelination by oligodendrocytes.
    Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB.
    Nat Neurosci; 2005 Jun 09; 8(6):745-51. PubMed ID: 15895088
    [Abstract] [Full Text] [Related]

  • 8. Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor.
    Vourc'h P, Moreau T, Arbion F, Marouillat-Védrine S, Müh JP, Andres C.
    J Neurochem; 2003 May 09; 85(4):889-97. PubMed ID: 12716421
    [Abstract] [Full Text] [Related]

  • 9. Reduction of oligodendrocyte myelin glycoprotein expression following facial nerve transection.
    Koyama Y, Fujiwara T, Kubo T, Tomita K, Yano K, Hosokawa K, Tohyama M.
    J Chem Neuroanat; 2008 Dec 09; 36(3-4):209-15. PubMed ID: 18809489
    [Abstract] [Full Text] [Related]

  • 10. The oligodendrocyte-myelin glycoprotein gene is highly expressed during the late stages of myelination in the rat central nervous system.
    Vourc'h P, Dessay S, Mbarek O, Marouillat Védrine S, Müh JP, Andres C.
    Brain Res Dev Brain Res; 2003 Sep 10; 144(2):159-68. PubMed ID: 12935913
    [Abstract] [Full Text] [Related]

  • 11. Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon.
    Gil V, Bichler Z, Lee JK, Seira O, Llorens F, Bribian A, Morales R, Claverol-Tinture E, Soriano E, Sumoy L, Zheng B, Del Río JA.
    Cereb Cortex; 2010 Aug 10; 20(8):1769-79. PubMed ID: 19892785
    [Abstract] [Full Text] [Related]

  • 12. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.
    Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H.
    J Neurosci Res; 2002 Aug 01; 69(3):305-17. PubMed ID: 12125072
    [Abstract] [Full Text] [Related]

  • 13. Expression of oligodendrocyte myelin glycoprotein and its receptor NgR after the injury of rat central nervous system.
    Guo Q, Li S, Su B.
    Neurosci Lett; 2007 Jul 11; 422(2):103-8. PubMed ID: 17630211
    [Abstract] [Full Text] [Related]

  • 14. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
    Padovani-Claudio DA, Liu L, Ransohoff RM, Miller RH.
    Glia; 2006 Oct 11; 54(5):471-83. PubMed ID: 16886211
    [Abstract] [Full Text] [Related]

  • 15. Beta IV tubulin is selectively expressed by oligodendrocytes in the central nervous system.
    Terada N, Kidd GJ, Kinter M, Bjartmar C, Moran-Jones K, Trapp BD.
    Glia; 2005 May 11; 50(3):212-22. PubMed ID: 15712210
    [Abstract] [Full Text] [Related]

  • 16. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
    Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M.
    Neuron; 2002 Jul 18; 35(2):283-90. PubMed ID: 12160746
    [Abstract] [Full Text] [Related]

  • 17. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT, Wu C, Fecenko-Tacka K.
    J Neurosci Res; 2004 Jul 01; 77(1):15-25. PubMed ID: 15197735
    [Abstract] [Full Text] [Related]

  • 18. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes.
    Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS.
    Neurosignals; 2010 Jul 01; 18(3):186-202. PubMed ID: 21242670
    [Abstract] [Full Text] [Related]

  • 19. Oligodendrocyte myelin glycoprotein does not influence node of ranvier structure or assembly.
    Chang KJ, Susuki K, Dours-Zimmermann MT, Zimmermann DR, Rasband MN.
    J Neurosci; 2010 Oct 27; 30(43):14476-81. PubMed ID: 20980605
    [Abstract] [Full Text] [Related]

  • 20. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system.
    Funahashi S, Hasegawa T, Nagano A, Sato K.
    J Comp Neurol; 2008 Jan 01; 506(1):141-60. PubMed ID: 17990276
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.